Company / Operating Cash Flow per Share
Relay Therapeutics, Inc. Operating Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.40
FY2025
5-year range
-$2.48 / -$0.74
FY2021-FY2025
Trend
+28.2%
vs FY2024
Sector context
#131 of 212
Health Care
What the data says
At $-1.40, Relay Therapeutics, Inc.'s operating cash flow per share ranks #131 of 212 in the Health Care sector. Improved from $-2.48 to $-1.40 over the past 2 years.
Based on SEC 10-K filings.
-1.40 in FY2025.
Improved from $-2.48 to $-1.40 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#131 of 212 in Health CareTop 62% of 212This company -$1.40 Sector average $5.28
▼
-126.6% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 28.2% year-over-year.
- Ranks #131 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2021.
- Lowest operating cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.40 | +28.2% |
| FY2024 | -$1.95 | +21.2% |
| FY2023 | -$2.48 | -161.8% |
| FY2022 | -$0.95 | -28.8% |
| FY2021 | -$0.74 | +95.5% |
| FY2020 | -$16.38 | +14.5% |
| FY2019 | -$19.17 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026